A Study With ABBV-155 Alone and in Combination With Taxane Therapy in Adults With Relapsed and/or Refractory Solid Tumors
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Advanced Solid Tumors
Interventions: DRUG: ABBV-155|DRUG: Paclitaxel|DRUG: Docetaxel
Sponsor: AbbVie